immunotherapy /saigenci/ en SAiGENCI researcher awarded funding in latest MRFF round /saigenci/news/list/2025/04/08/saigenci-researcher-awarded-funding-in-latest-mrff-round A SAiGENCI project using nanotechnology has received funding in the latest round of Medical Research Future Fund (MRFF) Early-to-Mid Career Researchers funding. April 08 2025 Debbie Wellington /saigenci/news/list/2025/04/08/saigenci-researcher-awarded-funding-in-latest-mrff-round SAiGENCI recruit recognised with prestigious award /saigenci/news/list/2023/05/18/saigenci-recruit-recognised-with-prestigious-award Professor Jenkins has been appointed as the Program Head for the Tumour Inflammation and Immunotherapy Program at the South ÐÓ°ÉÖ±²¥n ImmunoGENomics Cancer Institute (SAiGENCI), which operates within the ÐÓ°ÉÖ±²¥ of Adelaide’s Faculty of Health and Medical Sciences, and is supported by an alliance with the Central Adelaide Local Health Network (CALHN). May 18 2023 Debbie Wellington /saigenci/news/list/2023/05/18/saigenci-recruit-recognised-with-prestigious-award